| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/NAN.12198 |
| P698 | PubMed publication ID | 25405809 |
| P50 | author | Elisa Negroni | Q50589010 |
| Gillian Butler-Browne | Q56381067 | ||
| Anne Bigot | Q57418852 | ||
| Vincent Mouly | Q38304925 | ||
| Capucine Trollet | Q42323052 | ||
| P2093 | author name string | Teresa Gidaro | |
| P2860 | cites work | The fate of myoblasts following transplantation into mature muscle | Q45866758 |
| Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy | Q45883429 | ||
| Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. | Q45956233 | ||
| Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation | Q46050411 | ||
| Cell adhesion geometry regulates non-random DNA segregation and asymmetric cell fates in mouse skeletal muscle stem cells | Q46893450 | ||
| Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells | Q48034213 | ||
| Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up | Q48967108 | ||
| Direct isolation of satellite cells for skeletal muscle regeneration. | Q50756094 | ||
| Functional skeletal muscle regeneration from differentiating embryonic stem cells. | Q51966818 | ||
| Pluripotency of embryonic stem cells. | Q53515297 | ||
| The limb-girdle muscular dystrophies. | Q53939037 | ||
| Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. | Q54602083 | ||
| Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. | Q55052229 | ||
| Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients | Q57268472 | ||
| Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation | Q57268513 | ||
| Extended Amplification In Vitro and Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation | Q57268525 | ||
| A New Immunodeficient Mouse Model for Human Myoblast Transplantation | Q57268530 | ||
| Satellite cells and myonuclei in young and elderly women and men | Q57498082 | ||
| Transplantation of Human Myoblasts in SCID Mice as a Potential Muscular Model for Myotonic Dystrophy | Q58109248 | ||
| Very efficient myoblast allotransplantation in mice under FK506 immunosuppression | Q58109603 | ||
| High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice | Q43102507 | ||
| Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis | Q43203009 | ||
| Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts | Q43465378 | ||
| Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice | Q43769886 | ||
| Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume | Q43837773 | ||
| Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells | Q44810530 | ||
| Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy | Q22009039 | ||
| Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy | Q24308826 | ||
| Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy | Q24317622 | ||
| Emery-Dreifuss syndrome | Q24514959 | ||
| Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture | Q24623940 | ||
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| Matrix elasticity directs stem cell lineage specification | Q27860761 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Regenerative potential of human skeletal muscle during aging | Q28189702 | ||
| Muscle satellite cells | Q28205273 | ||
| Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues | Q28208566 | ||
| Progress and prospects: immune responses to viral vectors | Q28264531 | ||
| Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs | Q28274324 | ||
| A unifying genetic model for facioscapulohumeral muscular dystrophy | Q28291033 | ||
| Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMD | Q28389778 | ||
| Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers | Q28593090 | ||
| The mdx mouse model as a surrogate for Duchenne muscular dystrophy | Q28656377 | ||
| Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts | Q29302095 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Satellite cell of skeletal muscle fibers | Q29615148 | ||
| Why do we age? | Q29615672 | ||
| Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis | Q29619965 | ||
| Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy | Q30435398 | ||
| Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study | Q30575652 | ||
| Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength. | Q30576111 | ||
| The skeletal muscle satellite cell: the stem cell that came in from the cold. | Q30821824 | ||
| Resetting the Problem of Cell Death Following Muscle-Derived Cell Transplantation: Detection, Dynamics and Mechanisms | Q33193766 | ||
| A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog | Q33509682 | ||
| Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells | Q33559684 | ||
| Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization | Q33591765 | ||
| Human skeletal muscle xenograft as a new preclinical model for muscle disorders | Q33649287 | ||
| Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities | Q33713162 | ||
| Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. | Q33918478 | ||
| Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle | Q34002410 | ||
| Patient-specific pluripotent stem cells become even more accessible | Q34125353 | ||
| Hypervariable ultra-long telomeres in mice | Q34195724 | ||
| Are human and mouse satellite cells really the same? | Q34216980 | ||
| Telomeres, replicative senescence and human ageing | Q34224763 | ||
| The aged niche disrupts muscle stem cell quiescence. | Q34302715 | ||
| Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice | Q34306103 | ||
| Geriatric muscle stem cells switch reversible quiescence into senescence. | Q34403951 | ||
| Rejuvenation of the muscle stem cell population restores strength to injured aged muscles | Q34404503 | ||
| Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. | Q34437918 | ||
| Embryonic stem cell-specific microRNAs promote induced pluripotency | Q34606450 | ||
| Self-renewal and expansion of single transplanted muscle stem cells | Q34833140 | ||
| Interventions for muscular dystrophy: molecular medicines entering the clinic | Q35014916 | ||
| Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. | Q35124906 | ||
| Pharmacological strategies for muscular dystrophy | Q35128906 | ||
| Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs | Q35475301 | ||
| Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration | Q35665198 | ||
| Propagation and maintenance of undifferentiated human embryonic stem cells | Q35798464 | ||
| Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle | Q35835194 | ||
| Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances | Q35847178 | ||
| Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration | Q35883021 | ||
| Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. | Q35947481 | ||
| Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches | Q36059679 | ||
| The dystrophin-associated glycoprotein complex: what parts can you do without? | Q36126467 | ||
| Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source | Q36293384 | ||
| Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice | Q36771323 | ||
| Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. | Q36855778 | ||
| A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation | Q37157766 | ||
| Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy | Q37274303 | ||
| Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy | Q37386340 | ||
| Regulation and function of skeletal muscle stem cells | Q37388901 | ||
| Gene therapy for muscular dystrophy: current progress and future prospects. | Q37519650 | ||
| Invited review: myoblast transfer: a possible therapy for inherited myopathies? | Q37736435 | ||
| Current advances in cell therapy strategies for muscular dystrophies | Q37827157 | ||
| Cell therapy for muscular dystrophies: advances and challenges | Q37946144 | ||
| Stem cell therapies for muscle disorders | Q38037343 | ||
| Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy. | Q38092179 | ||
| PABPN1: molecular function and muscle disease | Q38100286 | ||
| Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence | Q38475944 | ||
| In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study | Q39502175 | ||
| Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models | Q40181500 | ||
| Derivation of engraftable skeletal myoblasts from human embryonic stem cells | Q40225312 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| Dynamics of the early immune cellular reactions after myogenic cell transplantation | Q40678854 | ||
| Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation | Q41136509 | ||
| Developmental Fate of Skeletal Muscle Satellite Cells | Q41760516 | ||
| Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse | Q41902045 | ||
| Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration | Q41985321 | ||
| A population of myogenic stem cells that survives skeletal muscle aging. | Q42506719 | ||
| Myoblast transfer in Duchenne muscular dystrophy | Q42512550 | ||
| Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study | Q42674399 | ||
| Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells | Q42807434 | ||
| Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. | Q42819955 | ||
| The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies | Q42934738 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 270-287 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Invited review: Stem cells and muscle diseases: advances in cell therapy strategies | |
| P478 | volume | 41 |
| Q34047674 | Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells. |
| Q35664379 | Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients |
| Q37036140 | Cellular dynamics of regeneration reveals role of two distinct Pax7 stem cell populations in larval zebrafish muscle repair |
| Q64071935 | Combined methods to evaluate human cells in muscle xenografts |
| Q42374498 | HGF potentiates extracellular matrix-driven migration of human myoblasts: involvement of matrix metalloproteinases and MAPK/ERK pathway |
| Q42109144 | Induced Pluripotent Stem Cells derived Muscle Progenitors Effectively Mitigate Muscular Dystrophy through Restoring the Dystrophin Distribution |
| Q64065154 | Isolation and characterization of myogenic precursor cells from human cremaster muscle |
| Q28087548 | Laminin therapy for the promotion of muscle regeneration |
| Q38440818 | Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies |
| Q52560156 | Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors. |
| Q38391853 | Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. |
| Q33630478 | Quiescence of human muscle stem cells is favored by culture on natural biopolymeric films. |
| Q46245053 | Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle. |
| Q36110110 | The Mutual Interactions between Mesenchymal Stem Cells and Myoblasts in an Autologous Co-Culture Model |
| Q26746647 | The emerging role of viral vectors as vehicles for DMD gene editing |
| Q92846144 | Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice |
Search more.